WO2009036925A1 - Procédé pour réduire les taches de vieillesse - Google Patents
Procédé pour réduire les taches de vieillesse Download PDFInfo
- Publication number
- WO2009036925A1 WO2009036925A1 PCT/EP2008/007483 EP2008007483W WO2009036925A1 WO 2009036925 A1 WO2009036925 A1 WO 2009036925A1 EP 2008007483 W EP2008007483 W EP 2008007483W WO 2009036925 A1 WO2009036925 A1 WO 2009036925A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- product applicator
- active ingredient
- product
- spray head
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 239000002537 cosmetic Substances 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 19
- 239000007921 spray Substances 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 7
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 claims description 6
- 208000012641 Pigmentation disease Diseases 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 238000009792 diffusion process Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 230000005693 optoelectronics Effects 0.000 claims description 4
- 230000001960 triggered effect Effects 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 230000019612 pigmentation Effects 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 claims description 2
- 230000006750 UV protection Effects 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 229960003258 hexylresorcinol Drugs 0.000 claims description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 2
- 229960004705 kojic acid Drugs 0.000 claims description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 2
- 239000000155 melt Substances 0.000 claims description 2
- 239000011814 protection agent Substances 0.000 claims description 2
- 206010040829 Skin discolouration Diseases 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 208000006981 Skin Abnormalities Diseases 0.000 claims 1
- 239000003708 ampul Substances 0.000 claims 1
- 230000037370 skin discoloration Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 239000000284 extract Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 206010004950 Birth mark Diseases 0.000 description 5
- -1 camitin Chemical compound 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000032628 PAR-2 Receptor Human genes 0.000 description 4
- 108010070503 PAR-2 Receptor Proteins 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 2
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229930013032 isoflavonoid Natural products 0.000 description 2
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 2
- 235000012891 isoflavonoids Nutrition 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- SBLKVIQSIHEQOF-OWOJBTEDSA-N (e)-octadec-9-enedioic acid Chemical compound OC(=O)CCCCCCC\C=C\CCCCCCCC(O)=O SBLKVIQSIHEQOF-OWOJBTEDSA-N 0.000 description 1
- GFBCWCDNXDKFRH-UHFFFAOYSA-N 4-(oxan-2-yloxy)phenol Chemical compound C1=CC(O)=CC=C1OC1OCCCC1 GFBCWCDNXDKFRH-UHFFFAOYSA-N 0.000 description 1
- 229940124125 5 Lipoxygenase inhibitor Drugs 0.000 description 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 1
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 description 1
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 description 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- CBQJSKKFNMDLON-JTQLQIEISA-N N-acetyl-L-phenylalanine Chemical compound CC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CBQJSKKFNMDLON-JTQLQIEISA-N 0.000 description 1
- CAHKINHBCWCHCF-JTQLQIEISA-N N-acetyl-L-tyrosine Chemical compound CC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CAHKINHBCWCHCF-JTQLQIEISA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- CIQHWLTYGMYQQR-QMMMGPOBSA-N O(4')-sulfo-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OS(O)(=O)=O)C=C1 CIQHWLTYGMYQQR-QMMMGPOBSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 244000003892 Vaccinium erythrocarpum Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- 229940033280 alpha-arbutin Drugs 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 108091006086 inhibitor proteins Proteins 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229930187586 licochalcone Natural products 0.000 description 1
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 229960001682 n-acetyltyrosine Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
- A61M15/025—Bubble jet droplet ejection devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
Definitions
- the present invention relates to a method for the selective application of cosmetic or pharmaceutical formulations to the skin and to a selective product applicator for cosmetic or pharmaceutical formulations.
- US 2006/0016999 A1 discloses a device which indicates to the user the type of cosmetic sunscreen preparation required.
- the intensity of the UVA and UVB radiation of the sunlight is detected by corresponding sensors.
- the preparation needed to protect the skin is calculated on the basis of appropriately preselected data on the individual skin properties and displayed to the user via optical or acoustic signals.
- an automatic application of the corresponding preparation does not take place.
- WO 04/039255 A1 discloses methods for the noninvasive analysis of the skin structure by means of optical methods. In particular, the methods shown are used to determine the melanin density.
- WO 02/087681 a method for the administration of therapeutic agents is known, in which a device implanted to the patient generates a signal which controls the delivery of an active ingredient from an adhesive plaster applied to the skin of the patient.
- a device implanted to the patient generates a signal which controls the delivery of an active ingredient from an adhesive plaster applied to the skin of the patient.
- no substances acting on or only in the upper layers of the skin can be used, since they do not or only in very small, ineffective amounts enter the body of a patient.
- the method of skin care or skin treatment is not suitable because only relatively small areas of skin can be covered with a patch. It is therefore an object of the present invention to provide a method and a suitable device which enable a selective application of cosmetic or pharmaceutical preparations for skin care or skin treatment, in particular for the treatment of age spots.
- the object is achieved in a first aspect by a method in which first the coloration of the skin, the skin relief or both over the entire surface of a selected skin surface is optically detected, the areas are determined within which the data deviate from target values, and then the cosmetic or pharmaceutical preparations are released on these surfaces.
- Preferred embodiments of the method are the subject of the subclaims.
- Age spots are in contrast to birthmarks in the skin level or are stored as melanin accumulations in the skin layers.
- moles have a skin profile, which means that birthmarks often stand out from the surrounding skin as elevation.
- birthmarks are skin lesions that should not be treated with active ingredients. The treatment of birthmarks should not be done without medical consultation, as this may put you at risk for uterine cancer 1 and 'melanoma'.
- Age spots on the other hand represent a disproportionate melanin deposition, whereby the pronounced staining is depth-dependent and melanin-dependent. It is therefore important and readily possible to distinguish age spots of birthmarks with profile in the inventive method.
- the amount of active substance applied must therefore, and this is the great advantage of the process according to the invention, be adapted to the depth and density of the deposited melanin.
- the object of the method is therefore to apply the active ingredients only to the age spots so that they bring about a uniform reduction effect.
- An advantage of the method is the rapid success and a saving of active ingredients through targeted treatment.
- a higher concentration of the active ingredient can be applied locally.
- the application of a high amount of active ingredient or high volume of active ingredient can lead to a diffusion of the active ingredient beyond the edge of the age spot, which can result in unsightly bright diffusion edges.
- the application of the pharmaceutical or cosmetic preparation is also corrected on the basis of the theological and diffusion properties of the preparation in such a way that leakage of the preparation from the specific area is avoided. For example, a very fluid solution might migrate beyond the age spot, since the goal is to treat only the area, the thin solution with a defined edge is
- the age spot would otherwise be more noticeable and stressed if around him a brighter edge arises.
- Measurements of the roughness of the skin by measuring the shadows of an obliquely illuminated skin area are known. The higher the elevations or deeper the grooves in the considered skin section, the longer shadows they cast.
- the light reflected on the skin surface is detected via corresponding sensors.
- the change in intensity, the change in the wavelength of the reflected light or both in comparison to the incident light are detected.
- the values obtained are compared with setpoints or setpoint ranges.
- the setpoint values can, for example, be determined in advance by appropriate measurements on wrinkle-free Skin areas with a lower relief depth or uniformly pigmented skin areas are determined.
- Another method for determining the setpoint values is, for example, to determine mean values from the measured values during the measurement itself, which values are used as setpoint values or setpoint range. It is important to be able to record the structure of the skin surface, either line-by-line (line scanner) or flat (CCD camera).
- Preparations which contain active ingredients are preferably used according to the invention.
- the choice of active ingredients depends on the type of skin change and the desired effect. For example, lightening, toning or anti-inflammatory agents are suitable for alleviating undesirable color changes.
- the inventive method is preferably used for targeted pigment whitening or staining. Furthermore, the method according to the invention can be used for targeted treatment of acne, inflammations, redness and irritation as well as insect bites.
- the pharmaceutical or cosmetic preparations used in the process according to the invention comprise active substances, individually or in combination, which are suitable for the particular application.
- Suitable active ingredients are, for example, the following active substances selected from the group of biochinones, in particular ubiquinone (Q10), ubiquinol, folic acid and its derivatives, in particular tetrahydrofolic acid and dihydrofolic acid, niacin and its derivatives i ⁇ , in particular niacinamide, creatine and creatinine, camitin, biotin, isoflavone, Cardiolipin, lipoic acid, anti-freezing proteins, pimpinella-anis-fruit-extract, hop and hop malt extracts, active ingredients that promote the restructuring of connective tissue such as natural and synthetic isoflavonoids and isoflavonoid-containing plant extracts such as soybean and clover Extracts, active ingredients to support skin functions in dry ner skin such as vitamin C, biotin, carnitine, propionic acid, green tea extracts, eucalyptus oil, urea and mineral salts such as NaCl, marine minerals and osmolytes
- Active substances in encapsulated form can also be used in the process according to the invention, the encapsulating materials being, for example, collagen matrices, cyclic oligosaccharides, in particular alpha-, beta-, HP-beta-, domed-Me-beta, gamma-cyclodextrin, cellulose, gelatin, wax or liposomes.
- the encapsulating materials being, for example, collagen matrices, cyclic oligosaccharides, in particular alpha-, beta-, HP-beta-, domed-Me-beta, gamma-cyclodextrin, cellulose, gelatin, wax or liposomes.
- whitening or skin-colored pigments UV protection agents
- rucinol (4-butylresorcinol) hexylresorcinol kojic acid, dioic acid.
- the present object is achieved by selective Fernapplika- gate, which at least one optoelectronic sensor, at least one product reservoir, a data processing unit and at least one electrically triggered Device for releasing liquids.
- Preferred embodiments of the product applicator are the subject of the subclaims.
- the opto-electronic sensors and the liquid-dispensing devices connected to the product reservoirs are connected to the data processing unit.
- the product applicator according to the invention has the form of a pin which can be actuated or applied with one hand. All components are chosen so that they can be arranged in a housing which can be held in one hand.
- the electrically triggered device for releasing liquids has a spray head.
- the spray head can be a
- Micro diaphragm pumps often use the piezo effect (piezo diaphragm micropumps) mentioned below.
- a preferred embodiment of the present invention is the use of overpressure containers and microvalves (corresponding to the technique used in the airbrush method).
- the spray head comprises a bubble jet spray head or a piezo spray head.
- a spray head according to the bubble jet method which is referred to below as a bubble jet spray head, tiny drops of liquid are produced by means of a heating element.
- explosive a spray head according to the bubble jet method
- the active ingredients and / or preparations are introduced by microinjections (microneedle system) directly into the Melaninansammlungen.
- microinjections microneedle system
- application types such as thermal inkjet, Mirkoventil and spraying using a Venturi nozzle (airbrush principle)
- the preparation to be released must not be too hot, so that the active ingredients are not destroyed.
- the viscosity, the maximum particle size and the agglomeration behavior of the particles of the preparation to be released must also be matched to the pumping power and the nozzle geometry of the device used in order to enable targeted release.
- CCD Charge Coupled Device
- the measured value acquisition according to the present invention is an evaluation of the light intensity distribution.
- a special optical arrangement e.g. Angle between the optical axes of the light source and the recording unit to better determine the wrinkle expression is to pay attention to the exact location assignment between the intensity signal and the application target area.
- the light intensity can be recorded as a sum signal or spectrally differentiating via optical or electronic filters.
- the trigger signal for the application can be obtained via a threshold value of the intensity or from threshold value combinations of different spectral intensities.
- the threshold value or the threshold value combinations must be determined individually for each skin in a "training mode.”
- optical iris may be required in order to focus the training particularly selectively on specific skin characteristics.
- the present object is achieved by the use of the product applicator according to the invention for the selective application of cosmetic or pharmaceutical preparations on the skin.
- the applicator according to the invention is preferred for the application of pharmaceutical and cosmetic preparations for the treatment of acne, wrinkles and other signs of aging as well as pigmentation disorders.
- Preparations suitable according to the invention are solutions, for example aqueous and / or alcoholic solutions (concentrates), emulsions, gels, melts, serums and make-up.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne un procédé d'application sélective de formulations cosmétiques ou pharmaceutiques sur la peau ainsi qu'un dispositif d'application sélective de produit destiné à des formulations cosmétiques ou pharmaceutiques.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007043698.1 | 2007-09-13 | ||
DE200710043698 DE102007043698A1 (de) | 2007-09-13 | 2007-09-13 | Selektiver Produktapplikator |
DE102008041971.0 | 2008-09-10 | ||
DE102008041971A DE102008041971A1 (de) | 2007-09-13 | 2008-09-10 | Verfahren zur Reduktion von Altersflecken |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009036925A1 true WO2009036925A1 (fr) | 2009-03-26 |
WO2009036925A8 WO2009036925A8 (fr) | 2009-07-09 |
Family
ID=40010886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/007483 WO2009036925A1 (fr) | 2007-09-13 | 2008-09-11 | Procédé pour réduire les taches de vieillesse |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102008041971A1 (fr) |
WO (1) | WO2009036925A1 (fr) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016191217A1 (fr) * | 2015-05-22 | 2016-12-01 | L'oreal | Applicateurs pour le traitement d'affections cutanées |
US10004885B2 (en) | 2015-05-22 | 2018-06-26 | L'oreal | Imaging applicator for treating skin conditions |
US10071233B2 (en) | 2015-05-22 | 2018-09-11 | L'oreal | Point applicator for treating skin conditions |
US10076646B2 (en) | 2015-05-22 | 2018-09-18 | L'oreal | Rolling applicator for treating skin conditions |
CN109125106A (zh) * | 2018-08-06 | 2019-01-04 | 上海优萃生物科技有限公司 | 一种祛皱原液及其在皮肤促渗技术上的应用 |
US10933156B2 (en) | 2018-02-01 | 2021-03-02 | The Procter & Gamble Company | System and method for dispensing material |
US10945515B2 (en) | 2017-06-16 | 2021-03-16 | The Procter & Gamble Company | Personal care device with audible feedback |
US11076675B2 (en) | 2017-06-16 | 2021-08-03 | The Procter & Gamble Company | Method for camouflaging tonal imperfections |
US11077689B2 (en) | 2015-12-07 | 2021-08-03 | The Procter & Gamble Company | Systems and methods for providing a service station routine |
US11083672B2 (en) | 2018-02-01 | 2021-08-10 | The Procter & Gamble Company | Cosmetic ink composition comprising a surface tension modifier |
US11090238B2 (en) | 2017-06-16 | 2021-08-17 | The Procter & Gamble Company | Array of cosmetic compositions for camouflaging tonal imperfections |
US11116302B2 (en) | 2015-06-11 | 2021-09-14 | The Procter & Gamble Company | Apparatus and methods for modifying keratinous surfaces |
USRE49230E1 (en) | 2015-06-11 | 2022-10-04 | The Procter & Gamble Company | Cartridges for use in an apparatus for modifying keratinous surfaces |
US11590782B2 (en) | 2015-12-07 | 2023-02-28 | The Procter & Gamble Company | Systems and methods for providing a service station routine |
US11833236B2 (en) | 2018-02-01 | 2023-12-05 | The Procter And Gamble Company | Heterogenous cosmetic ink composition for inkjet printing applications |
US11857665B2 (en) | 2018-02-01 | 2024-01-02 | The Procter And Gamble Company | Stable cosmetic ink composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102017114423A1 (de) | 2017-06-28 | 2019-01-03 | Schülke & Mayr GmbH | Verwendung von Alkylresorcinolen zur Verbesserung der Wirksamkeit von Kosmetikkonservierungsstoffen |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030065294A1 (en) * | 2001-09-28 | 2003-04-03 | Pickup Ray L. | Cutaneous administration system |
EP1459782A2 (fr) * | 2003-03-21 | 2004-09-22 | Hewlett-Packard Development Company, L.P. | Méthode et dispositif pour délivrer de manière visée des agents médiceaux où similaires |
WO2007022095A1 (fr) * | 2005-08-12 | 2007-02-22 | Yeager Rick B | Systeme et procede d'application d'un agent modifiant la reflectance pour ameliorer l'attrait visuel de la peau humaine |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2810761B1 (fr) * | 2000-06-26 | 2003-09-05 | Oreal | Procede et dispositif de traitement cosmetique,notamment de soin, de maquillage ou de coloration |
WO2002087681A2 (fr) | 2001-04-30 | 2002-11-07 | Medtronic,Inc. | Appareil medical implantable, systeme de timbre et procede d'utilisation |
GB0225060D0 (en) | 2002-10-29 | 2002-12-04 | Astron Clinica Ltd | Methods and apparatus for measuring tissue histology |
DE202004003148U1 (de) * | 2004-03-01 | 2005-03-24 | Merlaku Kastriot | Schmink-Gerät |
US20060016999A1 (en) | 2004-07-26 | 2006-01-26 | Angelfun Enterprises Co., Ltd. | Apparatus for displaying the necessary suntan lotion and the skin care |
CN101657155A (zh) * | 2007-02-11 | 2010-02-24 | 里克·B·耶格尔 | 用于通过化妆监视提供模拟图像的系统和方法 |
DE102007007612A1 (de) * | 2007-02-13 | 2008-08-14 | Beiersdorf Ag | Verfahren zur Depigmentierung der Haut |
DE102007043698A1 (de) * | 2007-09-13 | 2009-03-19 | Beiersdorf Ag | Selektiver Produktapplikator |
-
2008
- 2008-09-10 DE DE102008041971A patent/DE102008041971A1/de not_active Ceased
- 2008-09-11 WO PCT/EP2008/007483 patent/WO2009036925A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030065294A1 (en) * | 2001-09-28 | 2003-04-03 | Pickup Ray L. | Cutaneous administration system |
EP1459782A2 (fr) * | 2003-03-21 | 2004-09-22 | Hewlett-Packard Development Company, L.P. | Méthode et dispositif pour délivrer de manière visée des agents médiceaux où similaires |
WO2007022095A1 (fr) * | 2005-08-12 | 2007-02-22 | Yeager Rick B | Systeme et procede d'application d'un agent modifiant la reflectance pour ameliorer l'attrait visuel de la peau humaine |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107847720A (zh) * | 2015-05-22 | 2018-03-27 | 欧莱雅 | 用于治疗皮肤状况的涂抹器 |
US10004885B2 (en) | 2015-05-22 | 2018-06-26 | L'oreal | Imaging applicator for treating skin conditions |
US10071233B2 (en) | 2015-05-22 | 2018-09-11 | L'oreal | Point applicator for treating skin conditions |
US10076646B2 (en) | 2015-05-22 | 2018-09-18 | L'oreal | Rolling applicator for treating skin conditions |
EP3310425B1 (fr) * | 2015-05-22 | 2021-01-20 | L'Oréal | Applicateurs pour le traitement d'affections cutanées |
WO2016191217A1 (fr) * | 2015-05-22 | 2016-12-01 | L'oreal | Applicateurs pour le traitement d'affections cutanées |
USRE49230E1 (en) | 2015-06-11 | 2022-10-04 | The Procter & Gamble Company | Cartridges for use in an apparatus for modifying keratinous surfaces |
US11116302B2 (en) | 2015-06-11 | 2021-09-14 | The Procter & Gamble Company | Apparatus and methods for modifying keratinous surfaces |
US11077689B2 (en) | 2015-12-07 | 2021-08-03 | The Procter & Gamble Company | Systems and methods for providing a service station routine |
US11590782B2 (en) | 2015-12-07 | 2023-02-28 | The Procter & Gamble Company | Systems and methods for providing a service station routine |
US10945515B2 (en) | 2017-06-16 | 2021-03-16 | The Procter & Gamble Company | Personal care device with audible feedback |
US11090238B2 (en) | 2017-06-16 | 2021-08-17 | The Procter & Gamble Company | Array of cosmetic compositions for camouflaging tonal imperfections |
US11076675B2 (en) | 2017-06-16 | 2021-08-03 | The Procter & Gamble Company | Method for camouflaging tonal imperfections |
US11083672B2 (en) | 2018-02-01 | 2021-08-10 | The Procter & Gamble Company | Cosmetic ink composition comprising a surface tension modifier |
US11090239B2 (en) | 2018-02-01 | 2021-08-17 | The Procter & Gamble Company | Cosmetic ink composition comprising a surface tension modifier |
US10933156B2 (en) | 2018-02-01 | 2021-03-02 | The Procter & Gamble Company | System and method for dispensing material |
US11833236B2 (en) | 2018-02-01 | 2023-12-05 | The Procter And Gamble Company | Heterogenous cosmetic ink composition for inkjet printing applications |
US11857665B2 (en) | 2018-02-01 | 2024-01-02 | The Procter And Gamble Company | Stable cosmetic ink composition |
CN109125106A (zh) * | 2018-08-06 | 2019-01-04 | 上海优萃生物科技有限公司 | 一种祛皱原液及其在皮肤促渗技术上的应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2009036925A8 (fr) | 2009-07-09 |
DE102008041971A1 (de) | 2010-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009036925A1 (fr) | Procédé pour réduire les taches de vieillesse | |
WO2009036876A1 (fr) | Applicateur de produit sélectif | |
WO2009036924A1 (fr) | Procédé pour réduire les rides | |
JP6633001B2 (ja) | 角質表面を改質するための装置及び方法 | |
JP6374990B2 (ja) | 角質表面を改質するための装置及び方法 | |
JP6796493B2 (ja) | 角質表面を改質するための装置及び方法 | |
JP6374991B2 (ja) | トリートメント組成物を角質表面に付着させるためのカートリッジ | |
JP6374992B2 (ja) | 角質表面を改質するための装置及び方法 | |
JP6462110B2 (ja) | 角質表面を改質するための手持ち式処置装置用アプリケータヘッド | |
JP6931404B2 (ja) | 可聴フィードバックを有するパーソナルケアデバイス | |
US20210321744A1 (en) | Method For Camouflaging Tonal Imperfections | |
JP2019141684A (ja) | 角質表面を改質するための手持ち式処置装置 | |
CA3064501C (fr) | Reseau de compositions cosmetiques pour camoufler des imperfections tonales | |
JP2019005611A (ja) | 角質表面を改質するための手持ち式処理装置用アプリケータヘッド | |
JP2017526617A (ja) | 角質表面を改質するためのトリートメント組成物、装置及び方法 | |
WO2005002437A1 (fr) | Dispositif et procede pour determiner un niveau autorise d'exposition de la peau d'un sujet a un rayonnement uv | |
DE102004020644A1 (de) | Verfahren zur Bestimmung eines UVA- und UVB-Strahlung erfassenden integralen Sonnenschutzfaktors | |
BR112021011029A2 (pt) | Dispositivo e método para aplicação seletiva de composição tópica com o uso de valores-limite dinâmicos | |
AT11794U1 (de) | Einrichtung zur photodynamischen therapie des gewebes eines lebewesens | |
CN118284351A (zh) | 具有可听反馈的个人护理装置 | |
CH716867B1 (de) | Topisches kosmetisches Mittel zur Verwendung bei der Vorbeugung von Ergrauen von Haar und/oder Pflege von farblich wieder erholtem Haar und/oder der Wiederrückführung von ergrautem Haar zur ursprünglichen Haarfarbe. | |
DE102008009471A1 (de) | Verfahren zur Depigmentierung der Haut |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08802043 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08802043 Country of ref document: EP Kind code of ref document: A1 |